期刊文献+

替吉奥治疗进展期胃癌的临床疗效分析 被引量:7

Clinical Effect Analysis on Advanced Gastric Cancer Treated by S-1
下载PDF
导出
摘要 目的探讨替吉奥治疗进展期胃癌的临床效果。方法选取我院收治的进展期胃癌患者140例,随机分为两组,研究组应用替吉奥治疗,对照组应用奥沙利铂治疗。比较两组患者的临床疗效、不良反应发生率、生活质量。结果研究组临床疗效优于对照组,差异有统计学意义(P<0.05);研究组不良反应发生率低于对照组,差异有统计学意义(P<0.05);研究组生活质量高于对照组,差异有统计学意义(P<0.05)。结论替吉奥对进展期胃癌患者的治疗效果较好,值得临床推广使用。 Objective To investigate the clinical effect of S-1 in the treatment of advanced gastric cancer.Methods 140 patients with advanced gastric cancer treated in our hospital were randomly divided into two groups.The study group was treated with S-1,and the control group was treated with oxaliplatin.The clinical efficacy,incidence of adverse reactions and quality of life were compared between the two groups.Results The clinical efficacy was higher in the study group than in the control group(P<0.05).The incidence of adverse reactions in the study group was lower than in the control group(P<0.05).The quality of life in the study group was higher than in the control group(P<0.05).Conclusion S-1 achieved a good therapeutic effect in the treatment of patients with advanced gastric cancer.
作者 赵凯丰 肖罗 张静 刘学志 江道亮 苏立稳 ZHAO Kaifeng;XIAO Luo;ZHANG Jing;LIU Xuezhi;JIANG Daoliang;SU Liwen(Department of Gastroenterology,PLA 464 Hospital,Tianjin,300084,China)
机构地区 解放军第
出处 《肿瘤药学》 CAS 2018年第5期732-734,共3页 Anti-Tumor Pharmacy
基金 天津市中医药管理局资助项目(13148)
关键词 替吉奥 进展期胃癌 奥沙利铂 S-1 Advanced gastric cancer Oxaliplatin into
  • 相关文献

参考文献8

二级参考文献57

  • 1Ming Lu,Jing Gao, Xi-cheng Wang, Lin Shen.Expressions of Thymidylate Synthase, Thymidine Phosphorylase, Class Ⅲ β-tubulin, and Excision Repair Cross-complementing Group 1 Predict Response in Advanced Gastric Cancer Patients Receiving Capecitabine Plus Paclitaxel or Cisplatin[J].Chinese Journal of Cancer Research,2011,23(4):288-294. 被引量:22
  • 2Cunningham D,Allum WH,Stenning SP,菅鑫妍.手术期间化学疗法与单独手术治疗可切除的胃食管癌疗效比较[J].中国处方药,2006,5(8):59-60. 被引量:434
  • 3Casaretto L, Sousa PL, Mari JJ. Chemotherapy versus support cancer treatment in advanced gastric cancer: a meta-analysis [ J]. Braz J Med Biol Res, 2006, 39(4) :431-440. W.
  • 4agner AD, Gmthe W, I-Iaerting J, et al. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data [ J ]. J Clin Oncol, 2006, 24 ( 18 ) : 2903-2909. DOI: 10.1200/JCO.2005.05.0245.
  • 5Chong G, Cunningham D. Can cisplatin and infused 5-fluorouracil be replaced by oxaliplatin and capecitabine in the treatment of advanced oesophagogastric cancer? The REAL 2 trial [ J ]. Clin Oncol (R Coil Radiol) , 2005, 17(2) :79-80.
  • 6Zhang SH, Zhang H, He HW, et al. Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma [ J]. Cancer Chemother Pharmacol, 2013, 72 (4) : 777-788.DOI : 10.1007/s00280-013-2253-3.
  • 7Sakata K, Someya M, Matsumoto Y, et al. Gimeracil, an inhibitor of dihydropyrimidine dehydrogenase, inhibits the early step in homologous recombination [ J ]. Cancer Sci, 2011, 102 (9) : 1712- 1716.DOI : 10.1111/j. 1349-7006.2011.02004.x.
  • 8Van Cutsem E, Moiseyenko VM, Tjulandin S, et al. Phase BIstudy of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group [ J]. J Clin Oncol, 2006, 24 ( 31 ) : 4991-4997. DOI : 10.1200/JCO.2006.06.8429.
  • 9Schtiller J, Cassidy J, Dumont E, et al. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients [ J ]. Cancer Chemother Pharmacol, 2000, 45 (4) : 291-297.
  • 10Okines A, Chau I, Cunningham D. Capecitabine in advanced gastric cancer [ J ]. Expert Opin Pharmacother, 2007, 8 ( 16 ) : 2851-2861. DOI: 10.1517/14656566.8.16.2851.

共引文献189

同被引文献56

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部